Patents Assigned to CSL Behring Recombinant Facility AG
  • MUTATED TRUNCATED VON WILLEBRAND FACTOR
    Publication number: 20190015483
    Abstract: The present invention provides a modified polypeptide which binds Factor VIII. The polypeptide comprises truncated von Willebrand Factor (VWF) which comprises a sequence as shown in SEQ ID NO:3 or a fragment thereof or a sequence 90% identical thereto, wherein the truncated VWF comprises at least one modification in comparison to SEQ ID NO: 3 in at least one position selected from the group consisting of SI, S3, LI 8, V42, S43, K149, N248, S279, V320, T325, Q395 and K418.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 17, 2019
    Applicant: CSL BEHRING RECOMBINANT FACILITY AG
    Inventors: Arna ANDREWS, Con PANOUSIS, Kerstin EMMRICH, Michael WILSON, Steve DOWER, Matthew HARDY, Dallas HARTMAN
  • Syringe pump housing
    Patent number: D829434
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 2, 2018
    Assignees: CSL Behring Recombinant Facility AG, Medicom Innovation Partner a/s
    Inventor: Carsten Petersen
  • Syringe pump housing
    Patent number: D831194
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 16, 2018
    Assignees: CSL BEHRING RECOMBINANT FACILITY AG, MEDICOM INNOVATION PARTNER a/s
    Inventor: Carsten Petersen
  • Syringe pump housing
    Patent number: D831820
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 23, 2018
    Assignees: CSL BEHRING RECOMBINANT FACILITY AG, MEDICOM INNOVATION PARTNER a/s
    Inventor: Carsten Petersen
  • Syringe pump housing
    Patent number: D831821
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 23, 2018
    Assignees: CSL BEHRING RECOMBINANT FACILITY AG, MEDICOM INNOVATION PARTNER a/s
    Inventor: Carsten Petersen